COVID-19 Impact Analysis:

During the early phase of the COVID-19 pandemic, there was no availability of specific diagnostic tests to detect the virus in patients. Alternative diagnostic tests were used initially, which were not very effective.

The unavailability of specific COVID-19 diagnostic tests presented lucrative opportunities for diagnostic manufacturers to introduce their COVID-19 diagnostic kits. Many leading players as well as some start-ups from various countries utilized this opportunity and introduced COVID-19 diagnostics kits into local as well as global markets. These players achieved an edge over other diagnostics players capitalizing on the opportunity from the rise in demand for COVID-19 diagnostic tests, which, in turn, helps them in maintaining their revenues in such a crisis. Owing to such factors, COVID-19 is expected to have a significant impact on the multiplexed diagnostics market.

Top Impacting Factors:

• One of the primary factors that drive the growth of the multiplexed diagnostics market include therise in adoption of sedentary lifestyles and the increased incidence of malignancies and other infectious disorders.
• The need for multiplexed diagnostics is expected to rise as people become more concerned about an accurate and timely diagnosis of life-threatening diseases.
• The increase on emphasis on R&D activities aimed at generating next-generation sequencing solutions and the shift in preferences to use innovative medical technologies and equipment are important factors that drive the expansion of the multiplexed diagnostics market.
• The increase in funding in the fields of personalized medicine and genomics drives the global multiplexed diagnostics market.
• However, a shortage of skilled technicians to operate the equipment and expensive costs hamper the global multiplexed diagnostics market.

Market Trends:

New Product Launches to Flourish Multiplexed Diagnostics Market

• In May 2020, Eurofins Technologies launched its polymerase chain reaction to reverse transcriptase chain reaction (RT-PCR) CE-IVD marked multiplex for direct qualitative detection of the pathogen of the new coronavirus (SARS-CoV-2).
• In May 2019, QIAGEN launched the QIAstat-Dx syndromic testing system in the U.S. This is a multiplex molecular diagnostic system developed for the qualitative detection and identification of multiple respiratory bacterial and viral pathogens. QIAstat-Dx was launched along with a comprehensive respiratory panel that detects over 20 pathogens.
• The prevalence of disease outbreaks such as COVID-19 and Ebola virus is increasing. According to the World Health Organization (WHO), 87,137 cases of COVID-19 were reported globally on March 1st, 2020. The Democratic Republic of the Congo Ministry of Health (DRC MoH) also reported an Ebola outbreak in Congo's North Kivu province on August 1, 2018. Such occurrences are predicted to boost the demand for high-performance diagnostics in order to prevent false-positive test results and precisely identify the pathogen.

Key Benefits of Report

• This study presents the analytical depiction of the multiplexed diagnostics along with the current trends and future estimations to determine the imminent investment pockets.
• The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the multiplexed diagnostics market share.
• The current market is quantitatively analyzed from 2020 to 2030 to highlight the multiplexed diagnostics market growth scenario.
• Porter’s five forces analysis illustrates the potency of buyers & suppliers in the multiplexed diagnostics market. 
• The report provides a detailed multiplexed diagnostics market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions Answered in Multiplexed Diagnostics Market Report

• Who are the leading market players active in the multiplexed diagnostics market?
• What current trends will influence the multiplexed diagnostics market in the next few years?
• What are the driving factors, restraints, and opportunities in the multiplexed diagnostics market?
• What future projections would help in taking further strategic steps?
• What is multiplexed diagnostics?
• What is the multiplexed diagnostics market prediction for the future?
• Who are the leading global players in the multiplexed diagnostics market?
• What are the current trends and predicted trends?
• What are the key benefits of the multiplexed diagnostics market report?